Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age Related Macular Degeneration (AMD)”

640 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 640 results

Large-scale testing (Phase 3)Study completedNCT00590694
What this trial is testing

Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments

Who this might be right for
Age-related Macular DegenerationPigment Epithelial DetachmentNeovascular Macular Degeneration+1 more
Pacific Eye Associates 15
Not applicableEnded earlyNCT05112835
What this trial is testing

Brolucizumab Treatment Experience Study of Patients With nAMD in UK Routine Clinical Practice

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 302
Early research (Phase 1)Study completedNCT00791570
What this trial is testing

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Who this might be right for
Neovascular MaculopathyAge Related Macular Degeneration
Osaka University 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07607561
What this trial is testing

Phase 2a Study to Evaluate the Efficacy and Safety of SCAI-005 Ophthalmic Solution in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
wetAMDAge Related Macular Degeneration
SCAI Therapeutics 50
Not applicableLooking for participantsNCT07004361
What this trial is testing

Ethical Issues of Using Gene Therapy in the Treatment of AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Nantes University Hospital 30
Post-approval studies (Phase 4)UnknownNCT03468296
What this trial is testing

Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept

Who this might be right for
Neovascular Age-related Macular Degeneration
Tennessee Retina 22
Testing effectiveness (Phase 2)Temporarily pausedNCT05961007
What this trial is testing

Evaluation of IBI302 Injection in nAMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Innovent Biologics (Suzhou) Co. Ltd. 234
Large-scale testing (Phase 3)Study completedNCT04522167
What this trial is testing

Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Bioeq GmbH 434
Large-scale testing (Phase 3)Looking for participantsNCT07007065
What this trial is testing

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
AbbVie 561
Large-scale testing (Phase 3)Ended earlyNCT03577899
What this trial is testing

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 1,157
Large-scale testing (Phase 3)Study completedNCT04777201
What this trial is testing

Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche 1,036
Not applicableActive Not RecruitingNCT04645212
What this trial is testing

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 23
Post-approval studies (Phase 4)UnknownNCT02802657
What this trial is testing

Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Xiaodong Sun 141
Testing effectiveness (Phase 2)Ended earlyNCT02418754
What this trial is testing

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 505
Testing effectiveness (Phase 2)Study completedNCT05637255
What this trial is testing

A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Wet Macular DegenerationNeovascular Age-related Macular DegenerationMacular Degeneration
Sylentis, S.A. 99
Early research (Phase 1)UnknownNCT03675880
What this trial is testing

TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects

Who this might be right for
AMD
Lee's Pharmaceutical Limited 24
Not applicableUnknownNCT00640640
What this trial is testing

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Sheba Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT04304755
What this trial is testing

Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Oslo University Hospital 40
Not applicableStudy completedNCT04455399
What this trial is testing

Time Efficiency Comparison of Two IntraVitreal Injection Techniques

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion With Macular Edema+2 more
Peregrine Eye and Laser Institute 200
Not applicableStudy completedNCT05324150
What this trial is testing

M Charts Versus Amsler Test in Evaluating Metamorphopsia in nAMD

Who this might be right for
Macular Degeneration, WetMetamorphopsia
Ospedale Santa Croce-Carle Cuneo 57
Next Page